Learning from clinical phenotypes: Low‐dose biophotonics therapies in oral diseases

This narrative review on the use of biophotonics therapies for management of oral diseases is written as a tribute to Prof. Crispian Scully. His seminal contributions to the field are highlighted by the detailed, comprehensive description of clinical presentations of oral diseases. This has enabled...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oral diseases Ročník 24; číslo 1-2; s. 261 - 276
Hlavní autoři: Rahman, SU, Mosca, RC, Govindool Reddy, S, Nunez, SC, Andreana, S, Mang, TS, Arany, PR
Médium: Journal Article
Jazyk:angličtina
Vydáno: Denmark Wiley Subscription Services, Inc 01.03.2018
Témata:
anti‐microbial
Case reports
inflammation
Light therapy
low level light/laser therapy
Oral diseases
photobiomodulation therapy
Photodynamic therapy
Reviews
wound healing
oral diseases
wound healing
inflammation
photodynamic therapy
photobiomodulation therapy
low level light/laser therapy
anti-microbial
ISSN:1354-523X, 1601-0825, 1601-0825
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:This narrative review on the use of biophotonics therapies for management of oral diseases is written as a tribute to Prof. Crispian Scully. His seminal contributions to the field are highlighted by the detailed, comprehensive description of clinical presentations of oral diseases. This has enabled a more thorough, fundamental understanding of many of these pathologies by research from his group as well as inspired mechanistic investigations in many groups globally. In the same vein, a major emphasis of this narrative review is to focus on the evidence from human case reports rather than in vitro or in vivo animal studies that showcases the growing and broad impact of biophotonics therapies. The similarities and differences between two distinct forms of low‐dose biophotonics treatments namely photodynamic therapy and photobiomodulation therapy are discussed. As evident in this review, a majority of these reports provide promising evidence for their clinical efficacy. However, a lack of adequate technical details, precise biological rationale, and limited outcome measures limits the current utility of these treatments. Future investigations should attempt to address these shortcomings and develop better designed, rigorous, controlled studies to fully harness the tremendous potential of low‐dose biophotonics therapies.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1354-523X
1601-0825
1601-0825
DOI:10.1111/odi.12796